In an attempt to develop new therapeutic means in NAFLD, authors evaluated the beneficial effects of scoparone and found its action on Toll like receptors (TLR)-4/NF-κB axis with the improvement of pathophysiological elements, including OS (Table 1) [43]. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.